These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1518496)

  • 21. Plasma prolactin response to L-dopa TRH and metaclopramide in thyrotoxicosis.
    Delitala G; Masala A; Alagna S; Devilla L
    Biomedicine; 1976 Jul; 25(5):173-6. PubMed ID: 1000028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human growth hormone (hGH) stimulation tests: the sequential exercise and L-dopa procedure.
    Liberman B; Cesar FP; Wajchenberg BL
    Clin Endocrinol (Oxf); 1979 Jun; 10(6):649-54. PubMed ID: 476987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of pyridoxine on pituitary release of growth hormone and prolactin in childhood and adolescence.
    Reiter EO; Root AW
    J Clin Endocrinol Metab; 1978 Sep; 47(3):689-90. PubMed ID: 263321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-DOPA attenuates prolactin secretion in response to isolation stress in Holstein steers.
    Kasuya E; Yayou K; Sutoh M
    Anim Sci J; 2013 Jul; 84(7):562-8. PubMed ID: 23607456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of L-dopa and chlorpromazine on prolactin and growth hormone secretion in normal women.
    Leblanc H; Yen SS
    Am J Obstet Gynecol; 1976 Sep; 126(2):162-4. PubMed ID: 961756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of dopaminergic blockade to affect prolactin, growth hormone, and cortisol responses to insulin-induced hypoglycemia in schizophrenics.
    Nathan RS; Sachar EJ; Ostrow L; Asnis GM; Halbreich U; Halpern FS
    J Clin Endocrinol Metab; 1981 Apr; 52(4):807-9. PubMed ID: 7009631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of cimetidine on L-dopa-stimulated growth hormone release in normal man.
    Zanoboni A; Galmozzi G; Marinoni S; Zanoboni-Muciaccia W
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):535-40. PubMed ID: 6499233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prolactin response to metoclopramide in growth hormone deficient adolescent males.
    Cohen HN; Beastall GH; Fyffe JA; Fitzgerald V; Thomson JA
    Clin Endocrinol (Oxf); 1980 Aug; 13(2):207-11. PubMed ID: 7002371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of l-DOPA and sulpiride on growth hormone secretion at different injection times in Holstein steers.
    Kasuya E; Sutoh M; Yayou KI
    Anim Sci J; 2017 Nov; 88(11):1842-1848. PubMed ID: 28585780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of growth hormone release in children using arginine and L-dopa in combination.
    Weldon VV; Gupta SK; Klingensmith G; Clarke WL; Duck SC; Haymond MW; Pagliara AS
    J Pediatr; 1975 Oct; 87(4):540-4. PubMed ID: 1159580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemia.
    Lissoni P; Mandalà M; Rovelli F; Casu M; Rocco F; Tancini G; Scardino E
    Eur Urol; 2000 May; 37(5):569-72. PubMed ID: 10765095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin and growth hormone response to levodopa in affective illness.
    Linkowski P; Brauman H; Mendlewicz J
    Neuropsychobiology; 1983; 9(2-3):108-12. PubMed ID: 6621850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrity of central dopaminergic system in women with postpartum hyperprolactinemia.
    Rao R; Scommegna A; Frohman LA
    Am J Obstet Gynecol; 1982 Aug; 143(8):883-7. PubMed ID: 7102764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of modulation of pituitary hormone stress response by neural pathways involving opiate receptors.
    Spiler IJ; Molitch ME
    J Clin Endocrinol Metab; 1980 Mar; 50(3):516-20. PubMed ID: 6244322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of single and combined tests for the evaluation of plasma growth hormone secretion in normal short children.
    Bazán MC; Domené H; Heinrich JJ; Barontini M; Bergadá C
    J Endocrinol Invest; 1984 Aug; 7(4):295-8. PubMed ID: 6389660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
    Moriondo P; Travaglini P; Nissim M; Faglia G
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):525-33. PubMed ID: 7226570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone secretion and sulfation factor activity in pseudohypoparathyroidism.
    Urdanivia E; Mataverde A; Cohen MP
    J Lab Clin Med; 1975 Nov; 86(5):772-6. PubMed ID: 1185037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of L-dopa with and without decarboxylase inhibitor on growth hormone secretion in children with short stature.
    Fevang FO; Stoa RF; Thorsen T; Aarskog D
    Acta Paediatr Scand; 1977 Jan; 66(1):81-4. PubMed ID: 831384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does short-term fasting desensitize human somatotrophs to oral L-dopa stimulation?
    Röjdmark S
    Clin Endocrinol (Oxf); 1986 Dec; 25(6):721-8. PubMed ID: 3652472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.